Bero LA - Search Results

1

Characteristics and impact of drug detailing for gabapentin.

Steinman MA, Harper GM, Chren MM, Landefeld CS, Bero LA. Steinman MA, et al. Among authors: bero la. PLoS Med. 2007 Apr;4(4):e134. doi: 10.1371/journal.pmed.0040134. PLoS Med. 2007. PMID: 17455990 Free PMC article.

2

Narrative review: the promotion of gabapentin: an analysis of internal industry documents.

Steinman MA, Bero LA, Chren MM, Landefeld CS. Steinman MA, et al. Among authors: bero la. Ann Intern Med. 2006 Aug 15;145(4):284-93. doi: 10.7326/0003-4819-145-4-200608150-00008. Ann Intern Med. 2006. PMID: 16908919 Free article. Review.

3

Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.

Bero L, Oostvogel F, Bacchetti P, Lee K. Bero L, et al. PLoS Med. 2007 Jun;4(6):e184. doi: 10.1371/journal.pmed.0040184. PLoS Med. 2007. PMID: 17550302 Free PMC article.

4

Interactions between non-physician clinicians and industry: a systematic review.

Grundy Q, Bero L, Malone R. Grundy Q, et al. PLoS Med. 2013 Nov;10(11):e1001561. doi: 10.1371/journal.pmed.1001561. Epub 2013 Nov 26. PLoS Med. 2013. PMID: 24302892 Free PMC article. Review.

5

Influences on the quality of published drug studies.

Bero LA, Rennie D. Bero LA, et al. Int J Technol Assess Health Care. 1996 Spring;12(2):209-37. doi: 10.1017/s0266462300009582. Int J Technol Assess Health Care. 1996. PMID: 8707496 Review.

6

Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation.

Rising K, Bacchetti P, Bero L. Rising K, et al. PLoS Med. 2008 Nov 25;5(11):e217; discussion e217. doi: 10.1371/journal.pmed.0050217. PLoS Med. 2008. PMID: 19067477 Free PMC article.

7

Outcome reporting in industry-sponsored trials of gabapentin for off-label use.

Vedula SS, Bero L, Scherer RW, Dickersin K. Vedula SS, et al. N Engl J Med. 2009 Nov 12;361(20):1963-71. doi: 10.1056/NEJMsa0906126. N Engl J Med. 2009. PMID: 19907043 Free article.

8

Inclusion of training patients in US Food and Drug Administration premarket approval cardiovascular device studies.

Chen CE, Dhruva SS, Bero LA, Redberg RF. Chen CE, et al. Among authors: bero la. Arch Intern Med. 2011 Mar 28;171(6):534-9. doi: 10.1001/archinternmed.2010.445. Epub 2010 Nov 22. Arch Intern Med. 2011. PMID: 21098342

9

The publication of sponsored symposiums in medical journals.

Bero LA, Galbraith A, Rennie D. Bero LA, et al. N Engl J Med. 1992 Oct 15;327(16):1135-40. doi: 10.1056/NEJM199210153271606. N Engl J Med. 1992. PMID: 1528209 Free article.

10

The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing. A randomized controlled trial.

Lipton HL, Bero LA, Bird JA, McPhee SJ. Lipton HL, et al. Among authors: bero la. Med Care. 1992 Jul;30(7):646-58. doi: 10.1097/00005650-199207000-00006. Med Care. 1992. PMID: 1614233 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

345 results

Search Page